LAM
L2 Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
9,016
-11,384
| -56% | -$527K | 0.07% | 230 |
|
|
2025
Q1 | $1.24M | Buy |
20,400
+1,957
| +11% | +$119K | 0.25% | 84 |
|
|
2024
Q4 | $1.04M | Buy |
18,443
+3,304
| +22% | +$187K | 0.23% | 88 |
|
|
2024
Q3 | $783K | Buy |
15,139
+426
| +3% | +$22K | 0.21% | 82 |
|
|
2024
Q2 | $611K | Buy |
14,713
+8,428
| +134% | +$350K | 0.18% | 96 |
|
|
2024
Q1 | $341K | Buy |
+6,285
| New | +$341K | 0.11% | 142 |
|
|
2023
Q4 | – | Sell |
-977
| Closed | -$969K | – | 184 |
|
|
2023
Q3 | $969K | Sell |
977
-21,190
| -96% | -$21M | 0.46% | 62 |
|
|
2023
Q2 | $1.34M | Sell |
22,167
-38,838
| -64% | -$2.35M | 0.66% | 51 |
|
|
2023
Q1 | $4.23M | Buy |
61,005
+11,656
| +24% | +$808K | 2.33% | 7 |
|
|
2022
Q4 | $3.55M | Buy |
49,349
+618
| +1% | +$44.5K | 2.21% | 10 |
|
|
2022
Q3 | $3.46M | Buy |
48,731
+8,582
| +21% | +$610K | 2.38% | 8 |
|
|
2022
Q2 | $3.09M | Buy |
40,149
+27,977
| +230% | +$2.15M | 2.24% | 7 |
|
|
2022
Q1 | $889K | Buy |
12,172
+6,916
| +132% | +$505K | 0.51% | 59 |
|
|
2021
Q4 | $328K | Buy |
+5,256
| New | +$328K | 0.23% | 90 |
|
|
2021
Q3 | – | Sell |
-3,644
| Closed | -$243K | – | 62 |
|
|
2021
Q2 | $243K | Sell |
3,644
-342
| -9% | -$22.8K | 0.23% | 82 |
|
|
2021
Q1 | $252K | Sell |
3,986
-5,395
| -58% | -$341K | 0.26% | 76 |
|
|
2020
Q4 | $582K | Sell |
9,381
-2,386
| -20% | -$148K | 0.4% | 58 |
|
|
2020
Q3 | $709K | Buy |
+11,767
| New | +$709K | 0.57% | 45 |
|